EDAN GILAT: Open Payments
NPI 1497046841 · WORTHINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,899 in 98 payments from 17 companies in 2025. Trend: 2023 $460 · 2024 $1,157 · 2025 $1,899
Food & beverage: $1,899
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 19 | $478 |
| ABBVIE INC. | 30 | $425 |
| Otsuka America Pharmaceutical, Inc. | 11 | $195 |
| Neurocrine BioSciences, Inc. | 5 | $105 |
| Lundbeck LLC | 5 | $105 |
| Axsome Therapeutics, Inc. | 4 | $99 |
| Corium, LLC | 4 | $83 |
| Alkermes, Inc. | 3 | $73 |
| Supernus Pharmaceuticals, Inc. | 3 | $63 |
| E.R. Squibb & Sons, L.L.C. | 3 | $63 |
Products named: VRAYLAR, REXULTI, HETLIOZ, FANAPT, INGREZZA, Azstarys, Auvelity, Qelbree.
Industry payments across OH — which companies pay providers there.
